Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

GSK Lifts Annual Guidance Again Helped By Strong Launch Of RSV Vaccine, Steady Demand For Shingles Shot

By Vandana Singh
November 1, 8:25 AM
GSK plc (NYSE: GSK) reported Q3 FY23 s

GSK

Read More
2 minute read
  • General
  • Health Care

Ozempic Supply Is Running Low: Here’s Why That Can Be A Problem

By Aaron Bry
October 31, 5:23 PM
Ozempic, the diabetes drug also used as a so-called "miracle" weight-loss drug, has been sweeping through America and is now in limited supply.

LLY

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

What’s Going On With Biotech Contract Service Firm Catalent Stock Today?

By Vandana Singh
October 31, 3:03 PM
Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial.

CTLT

Read More
2 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Trading Ideas

Uphill Battle Ahead For Gene Therapy Player Sarepta, Analysts Lower Price Targets Following Duchenne Trial Miss

By Vandana Singh
October 31, 2:35 PM
Sarepta Therapeutics Inc's (NASDAQ: SRPT) EMBARK Phase 3 study of Elevidys in ambulatory boys (those who can walk) with Duchenne muscular dystrophy aged 4-7 years failed to 

SRPT

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News

Healthcare Service Provider Tenet Healthcare’s Q3 Earnings Beat On Higher Volumes; Tightens Guidance

By Vandana Singh
October 31, 2:30 PM
Tenet Healthcare Corp (NYSE: THC) reported Q3 net operating income of $101 million ($0.94 per diluted share), down from the $131 million ($1.16 per diluted share) 

THC

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Surgical Aesthetics Company Sientra Stock Nosediving Today?

By Vandana Singh
October 31, 1:41 PM
Sientra Inc (NASDAQ: SIEN) shares are down after the company withdrew its FY23 guidance and reported 

SIEN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • News
  • Trading Ideas

Diagnostic Firm Qiagen’s Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends

By Vandana Singh
October 31, 1:38 PM
Qiagen NV's (NASDAQ: QGEN) Q3 net sales of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at least $465 million CER, driven by 5% CER growth in the 

QGEN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Repligen’s Strong Q3 Recovery: CEO Says Pharma Orders Rebound, Analytics Business Grows

By Vandana Singh
October 31, 12:32 PM
Repligen Corporation (NASDAQ: RGEN) reported third-quarter (Q3) revenues of $141.19 million, down 30% Y/Y, beating the 

RGEN

Read More
2 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK

By Vandana Singh
October 31, 11:05 AM
GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have 

ARWR

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Why Are GE Healthcare Technologies (GEHC) Shares Gaining Today?

By Vandana Singh
October 31, 10:27 AM
GE Healthcare Technologies Inc (NASDAQ: GEHC) reported Q3 FY23 sales of $4.82 billion, up 5% Y/Y and 6% on an organic basis, slightly beating the 

GEHC

Posts pagination

Previous 1 … 130 131 132 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service